Real-World Experience and 36-Week Outcomes of Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy Treated With Mavacamten

被引：1
|
作者：
Reza, Nosheen [1 ]
Dubey, Anandkumar [2 ]
Carattini, Thomas [2 ]
Marzolf, Amy [1 ]
Hornsby, Nicole [1 ]
de Feria, Alejandro [1 ]
Mahmud, Nadim [1 ]
Schuler, Patricia [2 ]
Owens, Anjali Tiku [1 ]
机构：
[1] Univ Penn, Perelman Sch Med, Philadelphia, PA USA
[2] Bristol Myers Squibb, Princeton, NJ USA
来源：
JACC-HEART FAILURE | 2024年 / 12卷 / 06期
关键词：
D O I：
10.1016/j.jchf.2024.03.009
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1123 / 1125
页数：3
相关论文
共 50 条
  • [31] The European Medicines Agency assessment of mavacamten as treatment of symptomatic obstructive hypertrophic cardiomyopathy in adult patients
    DeVries, J. Hans
    Irs, Alar
    Hillege, Hans L.
    EUROPEAN HEART JOURNAL, 2023, 44 (37) : 3492 - 3494
  • [32] Incidence of newly recognized atrial fibrillation in patients with obstructive hypertrophic cardiomyopathy treated with Mavacamten
    Castrichini, Matteo
    Alsidawi, Said
    Geske, Jeffrey B.
    Newman, Darrell B.
    Arruda-Olson, Adelaide M.
    Bos, J. Martijn
    Ommen, Steve R.
    Siontis, Konstantinos C.
    Ackerman, Michael J.
    Giudicessi, John R.
    HEART RHYTHM, 2024, 21 (10) : 2065 - 2067
  • [33] Incidence and recurrence of atrial fibrillation among patients with obstructive hypertrophic cardiomyopathy treated with mavacamten: a single-center experience
    Liang, Lusha W.
    Lumish, Heidi S.
    Shimada, Yuichi J.
    Weiner, Shepard D.
    CLINICAL RESEARCH IN CARDIOLOGY, 2024,
  • [34] Real-World Impact of Mavacamten on Diastolic Function in Hypertrophic Cardiomyopathy: Insights Beyond Gradient Reduction
    Rao, Roopa A.
    Das, Mithilesh K.
    AMERICAN JOURNAL OF CARDIOLOGY, 2025, 242 : 95 - 96
  • [35] Effect of Mavacamten on Chinese Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy: The EXPLORER-CN Randomized Clinical Trial
    Tian, Zhuang
    Li, Liwen
    Li, Xiaoyan
    Wang, Jian'an
    Zhang, Qing
    Li, Zhanquan
    Peng, Daoquan
    Yang, Ping
    Ma, Wei
    Wang, Fang
    Jin, Wei
    Cheng, Xiang
    Sun, Jing
    Fu, Yiqun
    Lyu, Cheng
    Zhang, Shuyang
    JAMA CARDIOLOGY, 2023, 8 (10) : 957 - 965
  • [36] Characteristics of Patients With Obstructive Hypertrophic Cardiomyopathy in Real-World Community-Based Cardiovascular Practices
    Butzner, Michael
    Sarocco, Phil
    Maron, Martin S.
    Rowin, Ethan
    Teng, Chia-Chen
    Stanek, Eric
    Tan, Hiangkiat
    Robertson, Laura A.
    AMERICAN JOURNAL OF CARDIOLOGY, 2022, 174 : 120 - 125
  • [37] Differences in Healthcare Resource Use and Cost by Pharmacotherapy Among Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy: Real-World Analysis of Claims Data
    Butzner, Michael
    Papademetriou, Eros
    Potluri, Ravi
    Liu, Xing
    Shreay, Sanatan
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2024, 24 (06) : 801 - 811
  • [38] Mavacamten in adolescent patients with symptomatic obstructive hypertrophic cardiomyopathy: design of the Phase 3 SCOUT-HCM trial
    Rossano, Joseph
    Canter, Charles
    Wolf, Cordula
    Favatella, Nick
    Lockman, Jeff
    Puli, Shilpa
    Javidialsaadi, Atefeh
    Dyme, Joshua
    Crevar, Christina
    Mital, Seema
    CIRCULATION, 2024, 150
  • [39] Serial Changes in Ventricular Strain in Symptomatic Obstructive Hypertrophic Cardiomyopathy Treated With Mavacamten: Insights From the VALOR-HCM Trial
    Desai, Milind Y.
    Okushi, Yuichiro
    Gaballa, Andrew
    Wang, Qiuqing
    Geske, Jeffrey B.
    Owens, Anjali T.
    Saberi, Sara
    Wang, Andrew
    Cremer, Paul C.
    Sherrid, Mark
    Lakdawala, Neal K.
    Tower-Rader, Albree
    Fermin, David
    Naidu, Srihari S.
    Lampl, Kathy L.
    Sehnert, Amy J.
    Nissen, Steven E.
    Popovic, Zoran B.
    CIRCULATION-CARDIOVASCULAR IMAGING, 2024, 17 (09)
  • [40] REAL-WORLD DATA ON INEQUITY IN CLINICAL OUTCOMES AMONG ADULT PATIENTS DIAGNOSED WITH HYPERTROPHIC CARDIOMYOPATHY
    Krishnaswami, S.
    Tyagi, M.
    Cao, Z.
    VALUE IN HEALTH, 2024, 27 (06) : S39 - S39
12345